Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/1998
11/05/1998WO1998049131A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
11/05/1998WO1998048806A1 Indene compounds having activity as serms
11/05/1998WO1998048799A1 Protease inhibitors
11/05/1998WO1998037094A3 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998034602A3 Mediation of cytokines by melanin
11/05/1998WO1998034583A3 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
11/05/1998DE19718334A1 Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New benzylamine derivatives and phenylethylamine derivatives, processes for their preparation and their use as medicaments
11/05/1998CA2288073A1 Human lysophospholipase
11/05/1998CA2287989A1 Protease inhibitors
11/05/1998CA2287567A1 Protease inhibitors
11/05/1998CA2287244A1 Indene compounds having activity as serms
11/05/1998CA2278217A1 Phosphodiesterase 4-inhibiting diazepinoindolones
11/04/1998EP0875569A1 A human sodium dependent phosphate transporter (IPT-1)
11/04/1998EP0875568A1 Novel human neurotensin receptor type 2 and splice variants thereof
11/04/1998EP0875565A2 Novel G-protein coupled receptor (hfgan72y)
11/04/1998EP0875248A1 Use of hyaluronic acid for the preparation of an aqueous solution useful as intra-articular lavage liquid
11/04/1998EP0874864A1 Osteo antiviral protein
11/04/1998EP0874830A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
11/04/1998EP0874824A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998EP0874823A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998EP0874819A1 Imides as pde iii, pde iv and tnf inhibitors
11/04/1998EP0874808A1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases
11/04/1998EP0874621A1 Pharmaceutical compositions
11/03/1998US5830915 Oral diseases; skin disorders; antiinflammatory agents
11/03/1998US5830870 Prevent loss of muscle mass
11/03/1998US5830850 Methods for the treatment of bone resorption disorders, including osteoporosis
11/03/1998CA1340112C Supression of cell proliferation by decorin
10/1998
10/30/1998CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/29/1998WO1998048055A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998WO1998048016A1 Edg-1-like receptor
10/29/1998WO1998047892A1 Substituted imidazoles useful in the treatment of inflammatory diseases
10/29/1998WO1998047880A1 Isoxazole derivatives
10/29/1998WO1998047879A1 Substituted phenyl derivatives, their preparation and use
10/29/1998WO1998047866A2 Arylsecocholadiene derivatives
10/29/1998WO1998047861A1 Retinoid-like compounds
10/29/1998CA2297176A1 Substituted imidazoles useful in the treatment of inflammatory diseases
10/29/1998CA2288272A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998CA2287445A1 Arylsecocholadiene derivatives
10/29/1998CA2286865A1 Edg-1-like receptor
10/29/1998CA2286252A1 Retinoid-like compounds
10/29/1998CA2285424A1 Substituted phenyl derivatives, their preparation and use
10/28/1998EP0873992A1 Indene compounds having activity as SERMs
10/28/1998EP0873304A1 Metalloproteinase inhibitors
10/28/1998EP0873125A1 Composition containing diosgenin
10/28/1998CN1197076A Steroid compounds having contraceptive and anti-osteoporosis activity
10/28/1998CN1040432C Spiro piperdines derivatives and its prepn. and applications
10/28/1998CA2231746A1 A human sodium dependent phosphate transporter (ipt-1)
10/27/1998US5827844 Having an n-pyrrolidinyl or n-piperidinyl group
10/27/1998US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology
10/22/1998WO1998046751A1 Osteoprotegerin binding proteins and receptors
10/22/1998WO1998046743A1 Novel ldl-receptor
10/22/1998WO1998046731A1 Inhibitors for urokinase receptor
10/22/1998WO1998046644A1 Novel protein and process for producing the same
10/22/1998WO1998046643A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
10/22/1998WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA
10/22/1998WO1998046632A2 Inhibitors for urokinase receptor
10/22/1998WO1998046606A1 Novel compounds
10/22/1998WO1998046603A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998WO1998046582A1 Protease inhibitors
10/22/1998WO1998046563A1 Metalloproteinase inhibitors
10/22/1998WO1998046289A1 Biodegradable osteosynthesis implant
10/22/1998WO1998046264A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998WO1998046253A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
10/22/1998WO1998046233A1 Osteoblast-promoting pharmaceutical composition comprising a carnitine compound and dhea or dhea-s
10/22/1998CA2781623A1 Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
10/22/1998CA2706609A1 Osteoprotegerin binding proteins and receptors
10/22/1998CA2289476A1 Modified tnf.alpha. molecules, dna encoding such modified tnf.alpha. molecules and vaccines comprising such modified tnf.alpha. molecules and dna
10/22/1998CA2287465A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998CA2287085A1 Tumor necrosis factor receptor related proteins tango-63d and tango-63e
10/22/1998CA2286791A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
10/22/1998CA2286332A1 Inhibitors for urokinase receptor
10/22/1998CA2286078A1 Novel compounds
10/22/1998CA2285601A1 Protease inhibitors
10/22/1998CA2284726A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/22/1998CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/21/1998EP0871710A1 Recombinant c-proteinase and processes, methods and uses thereof
10/21/1998EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
10/21/1998EP0871663A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
10/21/1998EP0871623A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
10/21/1998EP0871471A1 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
10/21/1998EP0871457A1 Isolated stromal cells and methods of using the same
10/21/1998EP0871448A1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase
10/21/1998EP0871444A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
10/21/1998EP0871439A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds
10/21/1998CN1196720A Novel vitamin D analogues
10/21/1998CN1196264A Strong waist and anti-protrusion pill
10/20/1998US5824661 Sulfur-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
10/20/1998US5824504 Polynucleotides
10/15/1998WO1998045712A2 20 human secreted proteins
10/15/1998WO1998045316A1 Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same
10/15/1998WO1998045315A1 Estra-5(10),7-dienes with estrogenic activity
10/15/1998WO1998045309A1 Novel phosphate compounds and their use as medicaments
10/15/1998WO1998045292A1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties
10/15/1998WO1998045291A1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties
10/15/1998WO1998045268A1 Nicotinamide derivatives
10/15/1998WO1998045255A1 Calcilytic compounds
10/15/1998WO1998044940A1 Use of lactoferin in the treatment of allergen induced disorders
10/15/1998WO1998044929A1 Composition comprising a hydrolysed collagen protein and glucosamine for the treatment of arthroses
10/15/1998WO1998044925A1 Calcilytic compounds
1 ... 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 ... 820